Aerovate Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL) (NCT05557942) | Aerovate Therapeutics | 2022-11-02 |
| A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) (NCT05036135) | Aerovate Therapeutics | 2021-12-02 |
Track Aerovate Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.